BackBrickell Biotech Overview

Brickell Biotech Receivables

Brickell Biotech's receivables is $360K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$358000.00

Peer average

Loading

Brickell Biotech Receivables History

Loading

Brickell Biotech vs. peers: Receivables Comparison

Loading

Brickell Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brickell Biotech (BBI) FAQ

As of the most recent data (June 2022), BBI shows a receivables of $360K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBI's receivables is now $360K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Brickell Biotech is outperforming or lagging.

Tracking BBI's receivables over time shows whether Brickell Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $360K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Brickell Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $360K) with ownership activity and broader fundamentals.

Brickell Biotech's receivables is $360K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.